newsfilter
← Latest News
GlobeNewswire·

Voyager Provides Update on SOD1 ALS Gene Therapy Program

- Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash runway into mid-2027 – - All other programs remain on track; IND